PDB Short entry for 2HHJ HEADER ISOMERASE 28-JUN-06 2HHJ TITLE HUMAN BISPHOSPHOGLYCERATE MUTASE COMPLEXED WITH 2,3- TITLE 2 BISPHOSPHOGLYCERATE (15 DAYS) COMPND MOL_ID: 1; COMPND 2 MOLECULE: BISPHOSPHOGLYCERATE MUTASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: 2,3-BISPHOSPHOGLYCERATE MUTASE, ERYTHROCYTE, 2,3- COMPND 5 BISPHOSPHOGLYCERATE SYNTHASE, BPGM, BPG-DEPENDENT PGAM; COMPND 6 EC: 5.4.2.4, 5.4.2.1, 3.1.3.13; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET22B KEYWDS BISPHOSPHOGLYCERATE MUTASE, 2,3-BISPHOSPHOGLYCERATE, ISOMERASE EXPDTA X-RAY DIFFRACTION AUTHOR Y.WANG,W.GONG REVDAT 4 27-JUL-16 2HHJ 1 HETNAM HETSYN VERSN REVDAT 3 24-FEB-09 2HHJ 1 VERSN REVDAT 2 18-NOV-08 2HHJ 1 JRNL REVDAT 1 24-OCT-06 2HHJ 0 JRNL AUTH Y.WANG,L.LIU,Z.WEI,Z.CHENG,Y.LIN,W.GONG JRNL TITL SEEING THE PROCESS OF HISTIDINE PHOSPHORYLATION IN HUMAN JRNL TITL 2 BISPHOSPHOGLYCERATE MUTASE. JRNL REF J.BIOL.CHEM. V. 281 39642 2006 JRNL REFN ISSN 0021-9258 JRNL PMID 17052986 JRNL DOI 10.1074/JBC.M606421200 REMARK 2 REMARK 2 RESOLUTION. 1.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.83 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 387209.880 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 93.0 REMARK 3 NUMBER OF REFLECTIONS : 83760 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.182 REMARK 3 FREE R VALUE : 0.209 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : 8399 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.002 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.59 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 83.30 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 11098 REMARK 3 BIN R VALUE (WORKING SET) : 0.2410 REMARK 3 BIN FREE R VALUE : 0.2450 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 1231 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.007 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4143 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 59 REMARK 3 SOLVENT ATOMS : 760 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 15.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 18.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 5.22000 REMARK 3 B22 (A**2) : -3.12000 REMARK 3 B33 (A**2) : -2.10000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.16 REMARK 3 ESD FROM SIGMAA (A) : 0.14 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.19 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.13 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.200 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.200 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.830 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.000 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.520 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.850 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.660 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.31 REMARK 3 BSOL : 43.32 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : HAI.PARAM REMARK 3 PARAMETER FILE 4 : 3PGA.PARAM REMARK 3 PARAMETER FILE 5 : DPG.PARAM REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : HAI.TOP REMARK 3 TOPOLOGY FILE 4 : 3PGA.TOP REMARK 3 TOPOLOGY FILE 5 : PI.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2HHJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 30-JUN-06. REMARK 100 THE RCSB ID CODE IS RCSB038353. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-FEB-05 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BSRF REMARK 200 BEAMLINE : 3W1A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 88158 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.500 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.8 REMARK 200 DATA REDUNDANCY : 4.500 REMARK 200 R MERGE (I) : 0.06900 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 19.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.53 REMARK 200 COMPLETENESS FOR SHELL (%) : 92.3 REMARK 200 DATA REDUNDANCY IN SHELL : 3.30 REMARK 200 R MERGE FOR SHELL (I) : 0.43800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.760 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 37.97 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.00 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG6000, TEMPERATURE 289K, PH 7.50, REMARK 280 VAPOR DIFFUSION, HANGING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 24.34600 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 79.59700 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.77750 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 79.59700 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 24.34600 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 35.77750 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 257 REMARK 465 LYS A 258 REMARK 465 LYS A 259 REMARK 465 LEU A 260 REMARK 465 GLU A 261 REMARK 465 HIS A 262 REMARK 465 HIS A 263 REMARK 465 HIS A 264 REMARK 465 HIS A 265 REMARK 465 HIS A 266 REMARK 465 HIS A 267 REMARK 465 MET B 1 REMARK 465 GLN B 256 REMARK 465 ALA B 257 REMARK 465 LYS B 258 REMARK 465 LYS B 259 REMARK 465 LEU B 260 REMARK 465 GLU B 261 REMARK 465 HIS B 262 REMARK 465 HIS B 263 REMARK 465 HIS B 264 REMARK 465 HIS B 265 REMARK 465 HIS B 266 REMARK 465 HIS B 267 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 134 CG CD OE1 NE2 REMARK 470 GLU A 205 CG CD OE1 OE2 REMARK 470 LYS A 255 CG CD CE NZ REMARK 470 GLN B 134 CG CD OE1 NE2 REMARK 470 GLU B 239 CG CD OE1 OE2 REMARK 470 LYS B 255 CG CD CE NZ REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 ARG A 227 CD NE CZ NH1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 ND2 ASN A 49 O HOH A 3543 4566 1.59 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 NEP A 11 156.78 -49.44 REMARK 500 SER A 24 -124.48 54.17 REMARK 500 ALA A 187 -137.04 -134.82 REMARK 500 SER B 24 -124.18 55.10 REMARK 500 SER B 155 150.65 179.68 REMARK 500 ALA B 187 -139.46 -134.09 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B3306 DISTANCE = 5.19 ANGSTROMS REMARK 600 REMARK 600 HETEROGEN REMARK 600 (DG2, NEP) (DG2, 3PG) ARE PARTIALLY IN ALTERNATE CONFORMATIONS OF REMARK 600 EACH OTHER. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HAI A 2000 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DG2 B 2200 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DG2 A 2201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 3PG A 3200 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 3PG B 3201 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1T8P RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH NO LIGAND. REMARK 900 RELATED ID: 2H52 RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH 3-PHOSPHOGLYCERATE DBREF 2HHJ A 1 259 UNP P07738 PMGE_HUMAN 1 258 DBREF 2HHJ B 1 259 UNP P07738 PMGE_HUMAN 1 258 SEQADV 2HHJ LEU A 260 UNP P07738 EXPRESSION TAG SEQADV 2HHJ GLU A 261 UNP P07738 EXPRESSION TAG SEQADV 2HHJ HIS A 262 UNP P07738 EXPRESSION TAG SEQADV 2HHJ HIS A 263 UNP P07738 EXPRESSION TAG SEQADV 2HHJ HIS A 264 UNP P07738 EXPRESSION TAG SEQADV 2HHJ HIS A 265 UNP P07738 EXPRESSION TAG SEQADV 2HHJ HIS A 266 UNP P07738 EXPRESSION TAG SEQADV 2HHJ HIS A 267 UNP P07738 EXPRESSION TAG SEQADV 2HHJ LEU B 260 UNP P07738 EXPRESSION TAG SEQADV 2HHJ GLU B 261 UNP P07738 EXPRESSION TAG SEQADV 2HHJ HIS B 262 UNP P07738 EXPRESSION TAG SEQADV 2HHJ HIS B 263 UNP P07738 EXPRESSION TAG SEQADV 2HHJ HIS B 264 UNP P07738 EXPRESSION TAG SEQADV 2HHJ HIS B 265 UNP P07738 EXPRESSION TAG SEQADV 2HHJ HIS B 266 UNP P07738 EXPRESSION TAG SEQADV 2HHJ HIS B 267 UNP P07738 EXPRESSION TAG SEQRES 1 A 267 MET SER LYS TYR LYS LEU ILE MET LEU ARG NEP GLY GLU SEQRES 2 A 267 GLY ALA TRP ASN LYS GLU ASN ARG PHE CYS SER TRP VAL SEQRES 3 A 267 ASP GLN LYS LEU ASN SER GLU GLY MET GLU GLU ALA ARG SEQRES 4 A 267 ASN CYS GLY LYS GLN LEU LYS ALA LEU ASN PHE GLU PHE SEQRES 5 A 267 ASP LEU VAL PHE THR SER VAL LEU ASN ARG SER ILE HIS SEQRES 6 A 267 THR ALA TRP LEU ILE LEU GLU GLU LEU GLY GLN GLU TRP SEQRES 7 A 267 VAL PRO VAL GLU SER SER TRP ARG LEU ASN GLU ARG HIS SEQRES 8 A 267 TYR GLY ALA LEU ILE GLY LEU ASN ARG GLU GLN MET ALA SEQRES 9 A 267 LEU ASN HIS GLY GLU GLU GLN VAL ARG LEU TRP ARG ARG SEQRES 10 A 267 SER TYR ASN VAL THR PRO PRO PRO ILE GLU GLU SER HIS SEQRES 11 A 267 PRO TYR TYR GLN GLU ILE TYR ASN ASP ARG ARG TYR LYS SEQRES 12 A 267 VAL CYS ASP VAL PRO LEU ASP GLN LEU PRO ARG SER GLU SEQRES 13 A 267 SER LEU LYS ASP VAL LEU GLU ARG LEU LEU PRO TYR TRP SEQRES 14 A 267 ASN GLU ARG ILE ALA PRO GLU VAL LEU ARG GLY LYS THR SEQRES 15 A 267 ILE LEU ILE SER ALA HIS GLY ASN SER SER ARG ALA LEU SEQRES 16 A 267 LEU LYS HIS LEU GLU GLY ILE SER ASP GLU ASP ILE ILE SEQRES 17 A 267 ASN ILE THR LEU PRO THR GLY VAL PRO ILE LEU LEU GLU SEQRES 18 A 267 LEU ASP GLU ASN LEU ARG ALA VAL GLY PRO HIS GLN PHE SEQRES 19 A 267 LEU GLY ASP GLN GLU ALA ILE GLN ALA ALA ILE LYS LYS SEQRES 20 A 267 VAL GLU ASP GLN GLY LYS VAL LYS GLN ALA LYS LYS LEU SEQRES 21 A 267 GLU HIS HIS HIS HIS HIS HIS SEQRES 1 B 267 MET SER LYS TYR LYS LEU ILE MET LEU ARG NEP GLY GLU SEQRES 2 B 267 GLY ALA TRP ASN LYS GLU ASN ARG PHE CYS SER TRP VAL SEQRES 3 B 267 ASP GLN LYS LEU ASN SER GLU GLY MET GLU GLU ALA ARG SEQRES 4 B 267 ASN CYS GLY LYS GLN LEU LYS ALA LEU ASN PHE GLU PHE SEQRES 5 B 267 ASP LEU VAL PHE THR SER VAL LEU ASN ARG SER ILE HIS SEQRES 6 B 267 THR ALA TRP LEU ILE LEU GLU GLU LEU GLY GLN GLU TRP SEQRES 7 B 267 VAL PRO VAL GLU SER SER TRP ARG LEU ASN GLU ARG HIS SEQRES 8 B 267 TYR GLY ALA LEU ILE GLY LEU ASN ARG GLU GLN MET ALA SEQRES 9 B 267 LEU ASN HIS GLY GLU GLU GLN VAL ARG LEU TRP ARG ARG SEQRES 10 B 267 SER TYR ASN VAL THR PRO PRO PRO ILE GLU GLU SER HIS SEQRES 11 B 267 PRO TYR TYR GLN GLU ILE TYR ASN ASP ARG ARG TYR LYS SEQRES 12 B 267 VAL CYS ASP VAL PRO LEU ASP GLN LEU PRO ARG SER GLU SEQRES 13 B 267 SER LEU LYS ASP VAL LEU GLU ARG LEU LEU PRO TYR TRP SEQRES 14 B 267 ASN GLU ARG ILE ALA PRO GLU VAL LEU ARG GLY LYS THR SEQRES 15 B 267 ILE LEU ILE SER ALA HIS GLY ASN SER SER ARG ALA LEU SEQRES 16 B 267 LEU LYS HIS LEU GLU GLY ILE SER ASP GLU ASP ILE ILE SEQRES 17 B 267 ASN ILE THR LEU PRO THR GLY VAL PRO ILE LEU LEU GLU SEQRES 18 B 267 LEU ASP GLU ASN LEU ARG ALA VAL GLY PRO HIS GLN PHE SEQRES 19 B 267 LEU GLY ASP GLN GLU ALA ILE GLN ALA ALA ILE LYS LYS SEQRES 20 B 267 VAL GLU ASP GLN GLY LYS VAL LYS GLN ALA LYS LYS LEU SEQRES 21 B 267 GLU HIS HIS HIS HIS HIS HIS MODRES 2HHJ NEP A 11 HIS N1-PHOSPHONOHISTIDINE MODRES 2HHJ NEP B 11 HIS N1-PHOSPHONOHISTIDINE HET NEP A 11 14 HET NEP B 11 14 HET HAI A2000 7 HET DG2 B2200 15 HET DG2 A2201 15 HET 3PG A3200 11 HET 3PG B3201 11 HETNAM NEP N1-PHOSPHONOHISTIDINE HETNAM HAI CYCLOHEXYLAMMONIUM ION HETNAM DG2 (2R)-2,3-DIPHOSPHOGLYCERIC ACID HETNAM 3PG 3-PHOSPHOGLYCERIC ACID HETSYN DG2 2,3-BISPHOSPHOGLYCERIC ACID; 2,3-BISPHOSPHOGLYCERATE; HETSYN 2 DG2 2,3-BPG; 2,3-DIPHOSPHOGLYCERIC ACID; 2,3- HETSYN 3 DG2 DIPHOSPHOGLYCERATE; 2,3-DPG; (2~{R})-2,3- HETSYN 4 DG2 DIPHOSPHONOOXYPROPANOIC ACID FORMUL 1 NEP 2(C6 H10 N3 O5 P) FORMUL 3 HAI C6 H14 N 1+ FORMUL 4 DG2 2(C3 H8 O10 P2) FORMUL 6 3PG 2(C3 H7 O7 P) FORMUL 8 HOH *760(H2 O) HELIX 1 1 GLY A 14 GLU A 19 1 6 HELIX 2 2 ASN A 31 LEU A 48 1 18 HELIX 3 3 LEU A 60 GLY A 75 1 16 HELIX 4 4 TRP A 85 ASN A 88 5 4 HELIX 5 5 TYR A 92 ILE A 96 5 5 HELIX 6 6 ASN A 99 GLY A 108 1 10 HELIX 7 7 GLY A 108 SER A 118 1 11 HELIX 8 8 TYR A 132 ASN A 138 1 7 HELIX 9 9 ASP A 139 LYS A 143 5 5 HELIX 10 10 PRO A 148 LEU A 152 5 5 HELIX 11 11 SER A 157 ILE A 173 1 17 HELIX 12 12 ILE A 173 ARG A 179 1 7 HELIX 13 13 HIS A 188 GLY A 201 1 14 HELIX 14 14 GLU A 205 ILE A 210 5 6 HELIX 15 15 ASP A 237 GLN A 251 1 15 HELIX 16 16 GLY B 14 ASN B 20 1 7 HELIX 17 17 ASN B 31 LEU B 48 1 18 HELIX 18 18 LEU B 60 GLY B 75 1 16 HELIX 19 19 TRP B 85 ASN B 88 5 4 HELIX 20 20 TYR B 92 ILE B 96 5 5 HELIX 21 21 ASN B 99 GLY B 108 1 10 HELIX 22 22 GLY B 108 SER B 118 1 11 HELIX 23 23 TYR B 132 ASN B 138 1 7 HELIX 24 24 ASP B 139 LYS B 143 5 5 HELIX 25 25 PRO B 148 LEU B 152 5 5 HELIX 26 26 SER B 157 ARG B 172 1 16 HELIX 27 27 ARG B 172 ARG B 179 1 8 HELIX 28 28 HIS B 188 GLY B 201 1 14 HELIX 29 29 GLU B 205 ILE B 210 5 6 HELIX 30 30 ASP B 237 GLN B 251 1 15 SHEET 1 A 6 VAL A 81 SER A 83 0 SHEET 2 A 6 LEU A 54 THR A 57 1 N THR A 57 O GLU A 82 SHEET 3 A 6 ILE A 183 ALA A 187 1 O LEU A 184 N PHE A 56 SHEET 4 A 6 TYR A 4 ARG A 10 1 N LEU A 9 O ALA A 187 SHEET 5 A 6 ILE A 218 LEU A 222 -1 O LEU A 222 N TYR A 4 SHEET 6 A 6 GLN A 233 PHE A 234 -1 O GLN A 233 N LEU A 219 SHEET 1 B 6 VAL B 81 SER B 83 0 SHEET 2 B 6 LEU B 54 THR B 57 1 N VAL B 55 O GLU B 82 SHEET 3 B 6 ILE B 183 ALA B 187 1 O SER B 186 N PHE B 56 SHEET 4 B 6 TYR B 4 ARG B 10 1 N LEU B 9 O ALA B 187 SHEET 5 B 6 ILE B 218 LEU B 222 -1 O LEU B 220 N LEU B 6 SHEET 6 B 6 GLN B 233 PHE B 234 -1 O GLN B 233 N LEU B 219 LINK C ARG A 10 N NEP A 11 1555 1555 1.33 LINK C NEP A 11 N GLY A 12 1555 1555 1.33 LINK C ARG B 10 N NEP B 11 1555 1555 1.33 LINK C NEP B 11 N GLY B 12 1555 1555 1.33 SITE 1 AC1 3 LEU A 95 HIS A 107 PRO A 124 SITE 1 AC2 19 ARG B 10 NEP B 11 ASN B 17 PHE B 22 SITE 2 AC2 19 CYS B 23 SER B 24 ARG B 62 GLU B 89 SITE 3 AC2 19 TYR B 92 ARG B 100 ARG B 116 ARG B 117 SITE 4 AC2 19 HIS B 188 GLY B 189 ASN B 190 HOH B3212 SITE 5 AC2 19 HOH B3345 HOH B3422 HOH B3423 SITE 1 AC3 19 ARG A 10 NEP A 11 ASN A 17 PHE A 22 SITE 2 AC3 19 CYS A 23 SER A 24 ARG A 62 GLU A 89 SITE 3 AC3 19 TYR A 92 ARG A 100 ARG A 116 ARG A 117 SITE 4 AC3 19 HIS A 188 GLY A 189 ASN A 190 HOH A3236 SITE 5 AC3 19 HOH A3238 HOH A3465 HOH A3466 SITE 1 AC4 15 ARG A 10 NEP A 11 PHE A 22 CYS A 23 SITE 2 AC4 15 SER A 24 GLU A 89 TYR A 92 ARG A 100 SITE 3 AC4 15 ARG A 116 ARG A 117 ASN A 190 HOH A3236 SITE 4 AC4 15 HOH A3238 HOH A3465 HOH A3466 SITE 1 AC5 15 ARG B 10 NEP B 11 PHE B 22 CYS B 23 SITE 2 AC5 15 SER B 24 GLU B 89 TYR B 92 ARG B 100 SITE 3 AC5 15 ARG B 116 ARG B 117 ASN B 190 HOH B3212 SITE 4 AC5 15 HOH B3345 HOH B3422 HOH B3423 CRYST1 48.692 71.555 159.194 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020537 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013975 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006282 0.00000